Diagnosis and treatment of Guillain-Barré Syndrome in childhood and adolescence: An evidence- and consensus-based guideline

European Journal of Paediatric Neurology - Tập 25 - Trang 5-16 - 2020
R. Korinthenberg1, R. Trollmann2, U. Felderhoff-Müser3, G. Bernert4, A. Hackenberg5, M. Hufnagel6, M. Pohl7, G. Hahn8, H.J. Mentzel9, C. Sommer10, J. Lambeck11, F. Mecher12, M. Hessenauer13, C. Winterholler14, U. Kempf15, B.C. Jacobs16, K. Rostasy17, W. Müller-Felber18
1Division of Neuropediatrics and Muscular Disorders, Department of Pediatrics and Adolescent Medicine, Faculty of Medicine, University Medical Center (UMC), University of Freiburg, Germany
2Department of Neuropediatrics, UMC, Friedrich- Alexander University Erlangen-Nürnberg, Erlangen, Germany
3Department of Pediatrics, UMC, University of Essen, Germany
4Department of Pediatrics, Kaiser-Franz-Joseph-Hospital with Preyer's Childrens Hospital, Vienna, Austria
5Department of Pediatric Neurology, University Children's Hospital, Zürich, Switzerland
6Division of Pediatric Infectious Diseases and Rheumatology, Department of Pediatrics and Adolescent Medicine, Faculty of Medicine, UMC, University of Freiburg, Germany
7Section Pediatric Nephrology, Department of Pediatrics and Adolescent Medicine, Faculty of Medicine, UMC, University of Freiburg, Germany
8Department of Radiological Diagnostics, UMC, University of Dresden, Germany
9Section Pediatric Radiology, Institute of Diagnostic and Interventional Radiology, Universitätsklinikum Jena, Germany
10Department of Neurology, UMC, University of Wuerzburg, Germany
11Department of Neurology and Neurophysiology, UMC, University of Freiburg, Germany
12Physio Deutschland, German Federal Association for Physiotherapy, Germany
13Centre for Pediatric Neurology, Neurorehabilitation and Epileptology, Schoen Clinic Vogtareuth, Germany
14German Federal Association of Logopedics (dbl e.V. Deutscher Bundesverband für Logopädie e.v), Germany
15Mother of a GBS PPatient, Kraichtal-Neuenbürg, Germany
16Departments of Neurology and Immunology, Erasmus MC, UMC Rotterdam, the Netherlands
17Department of Neuropediatrics, Children´s Hospital Datteln, University Witten/Herdecke, Germany
18Department of Neuropediatrics, UMC, LMU Munich, Germany

Tài liệu tham khảo

Sejvar, 2011, Population incidence of Guillain-Barre syndrome: a systematic review and meta-analysis, Neuroepidemiology, 36, 123, 10.1159/000324710

Van der Meche, 2001, Diagnostic and classification criteria for the Guillain-Barre syndrome, Eur. Neurol., 45, 133, 10.1159/000052111

Wakerley, 2014, Guillain-Barre and Miller Fisher syndromes--new diagnostic classification, Nat. Rev. Neurol., 10, 537, 10.1038/nrneurol.2014.138

McMillan, 2013, Childhood chronic inflammatory demyelinating polyradiculoneuropathy: combined analysis of a large cohort and eleven published series, Neuromuscul. Disord., 23, 103, 10.1016/j.nmd.2012.09.008

Hughes, 2014, Intravenous immunoglobulin for Guillain-Barre syndrome, Cochrane Database Syst. Rev.

Chevret, 2017, Plasma exchange for Guillain-Barre syndrome, Cochrane Database Syst. Rev., 2

Korinthenberg, 1996, Natural history and treatment effects in Guillain-Barré syndrome: a multicentre study, Arch. Dis. Child., 74, 281, 10.1136/adc.74.4.281

Vajsar, 2003, Long-term outcome in children with Guillain-Barre syndrome, J. Pediatr., 142, 305, 10.1067/mpd.2003.115

Roodbol, 2014, Long-term outcome of Guillain-Barre syndrome in children, J. Peripher. Nerv. Syst., 19, 121, 10.1111/jns5.12068

Ortiz-Corredor, 2007, Motor recovery after Guillain-Barre syndrome in childhood, Disabil. Rehabil., 29, 883, 10.1080/09638280701240326

Tekgul, 2003, Outcome of axonal and demyelinating forms of Guillain-Barre syndrome in children, Pediatr. Neurol., 28, 295, 10.1016/S0887-8994(02)00626-4

Varkal, 2015, Pediatric Guillain-Barré syndrome: indicators for a severe course, Ann. Indian Acad. Neurol., 18, 24

Asbury, 1990, Assessment of current diagnostic criteria for Guillain-Barré syndrome, Ann. Neurol., 27, S21, 10.1002/ana.410270707

Sejvar, 2011, Guillain-Barre syndrome and Fisher syndrome: case definitions and guidelines for collection, analysis, and presentation of immunization safety data, Vaccine, 29, 599, 10.1016/j.vaccine.2010.06.003

Fokke, 2014, Diagnosis of Guillain-Barre syndrome and validation of Brighton criteria, Brain, 137, 33, 10.1093/brain/awt285

Roodbol, 2017, Diagnosis of Guillain-Barre syndrome in children and validation of the Brighton criteria, J. Neurol., 264, 856

Kahlmann, 2017, Validated age-specific reference values for CSF total protein levels in children, Eur. J. Paediatr. Neurol., 21, 654, 10.1016/j.ejpn.2017.03.006

Doctor, 2018, Guillain-Barre syndrome with exaggerated pleocytosis and anti-GM1 ganglioside antibodies, BMJ Case Rep., 2018

Hughes, 2005, Guillain-Barre syndrome, Lancet, 366, 1653, 10.1016/S0140-6736(05)67665-9

Uncini, 2012, Electrodiagnostic criteria for Guillain-Barre syndrome: a critical revision and the need for an update, Clin. Neurophysiol., 123, 1487, 10.1016/j.clinph.2012.01.025

Van den Bergh, 2018

Alberti, 2011, Very early electrodiagnostic findings in Guillain-Barre syndrome, J. Peripher. Nerv. Syst., 16, 136, 10.1111/j.1529-8027.2011.00338.x

Almeida, 2012, Nerve ultrasound follow-up in a child with Guillain-Barre syndrome, Muscle Nerve, 46, 270, 10.1002/mus.23325

Grimm, 2016, Ultrasound and electrophysiologic findings in patients with Guillain-Barre syndrome at disease onset and over a period of six months, Clin. Neurophysiol., 127, 1657, 10.1016/j.clinph.2015.06.032

Berciano, 2017, Proximal nerve lesions in early Guillain-Barré syndrome: implications for pathogenesis and disease classification, J. Neurol., 264, 221

Jacobs, 1998, The spectrum of antecedent infections in Guillain-Barré syndrome: a case-control study, Neurology, 51, 1110, 10.1212/WNL.51.4.1110

Meyer, 2016, Mycoplasma pneumoniae triggering the Guillain-Barre syndrome: a case-control study, Ann. Neurol., 80, 566, 10.1002/ana.24755

Schessl, 2006, Infections and vaccinations preceding childhood Guillain-Barre syndrome: a prospective study, Eur. J. Pediatr., 165, 605, 10.1007/s00431-006-0140-1

Andrews, 2011, Guillain-Barre syndrome and H1N1 (2009) pandemic influenza vaccination using an AS03 adjuvanted vaccine in the United Kingdom: self-controlled case series, Vaccine, 29, 7878, 10.1016/j.vaccine.2011.08.069

Haber, 2009, Vaccines and guillain-barre syndrome, Drug Saf., 32, 309, 10.2165/00002018-200932040-00005

Kuijf, 2005, Diagnostic value of anti-GM1 ganglioside serology and validation of the INCAT-ELISA, J. Neurol. Sci., 239, 37, 10.1016/j.jns.2005.07.009

Willison, 2002, Peripheral neuropathies and anti-glycolipid antibodies, Brain, 125, 2591, 10.1093/brain/awf272

Kuwabara, 2013, Axonal Guillain-Barre syndrome: concepts and controversies, Lancet Neurol., 12, 1180, 10.1016/S1474-4422(13)70215-1

Vural, 2018, Autoantibodies against the node of ranvier in seropositive chronic inflammatory demyelinating polyneuropathy: diagnostic, pathogenic, and therapeutic relevance, Front. Immunol., 9, 1029, 10.3389/fimmu.2018.01029

Sommer C. Therapie akuter und chronischer immunvermittelter Neuropathien und Neuritiden, S2e-Leitlinie. In: Deutsche Gesellschaft für Neurologie, editor. (Leitlinien für Diagnostik und Therapie in der Neurologie).

Renz, 2018, Comparison of unenhanced T1-weighted signal intensities within the dentate nucleus and the globus pallidus after serial applications of gadopentetate dimeglumine versus gadobutrol in a pediatric population, Investig. Radiol., 53, 119, 10.1097/RLI.0000000000000419

Mulkey, 2010, Nerve root enhancement on spinal MRI in pediatric Guillain-Barré syndrome, Pediatr. Neurol., 43, 263, 10.1016/j.pediatrneurol.2010.05.011

Yikilmaz, 2010, Magnetic resonance imaging of childhood Guillain-Barre syndrome, Childs Nerv Syst, 26, 1103, 10.1007/s00381-010-1197-8

Zuccoli, 2011, Redefining the Guillain-Barré spectrum in children: neuroimaging findings of cranial nerve involvement, AJNR Am J Neuroradiol, 32, 639, 10.3174/ajnr.A2358

Ogna, 2017, Swallowing and swallowing-breathing interaction as predictors of intubation in Guillain-Barre syndrome, Brain Behav, 7, 10.1002/brb3.611

van Nes, 2008, Outcome measures in immune-mediated neuropathies: the need to standardize their use and to understand the clinimetric essentials, J. Peripher. Nerv. Syst., 13, 136, 10.1111/j.1529-8027.2008.00169.x

Bond, 2007

Vanhoutte, 2015, Rasch-ionale for neurologists, J. Peripher. Nerv. Syst., 20, 260, 10.1111/jns.12122

Hughes, 2005, Supportive care for patients with Guillain-Barre syndrome, Arch. Neurol., 62, 1194, 10.1001/archneur.62.8.1194

Korinthenberg, 2007, Clinical presentation and course of childhood Guillain-Barre syndrome: a prospective multicentre study, Neuropediatrics, 38, 10, 10.1055/s-2007-981686

Walgaard, 2017, Tracheostomy or not: prediction of prolonged mechanical ventilation in guillain-barre syndrome, Neurocritical Care, 26, 6, 10.1007/s12028-016-0311-5

Samadi, 2013, Assessment of autonomic dysfunction in childhood guillain-barré syndrome, J. Cardiovasc. Thorac. Res., 5, 81

Nabi, 2016, Posterior reversible encephalopathy syndrome (PRES) as a complication of Guillain-Barre' syndrome (GBS), BMJ Case Rep., 2016

Roodbol, 2011, Recognizing Guillain-Barre syndrome in preschool children, Neurology, 76, 807, 10.1212/WNL.0b013e31820e7b62

Mistry, 2007, Experiencing Guillain Barre: a mother and daughter perspective, Arch. Dis. Child., 92, 462, 10.1136/adc.2006.111369

Kuitwaard, 2009, Recurrences, vaccinations and long-term symptoms in GBS and CIDP, J. Peripher. Nerv. Syst., 14, 310, 10.1111/j.1529-8027.2009.00243.x

Korinthenberg, 2005, Intravenously administered immunoglobulin in the treatment of childhood Guillain-Barre syndrome: a randomized trial, Pediatrics, 116, 8, 10.1542/peds.2004-1324

Singh-Grewal, 2006, A prospective study of the immediate and delayed adverse events following intravenous immunoglobulin infusions, Arch. Dis. Child., 91, 651, 10.1136/adc.2005.078733

Cortese, 2011, Evidence-based guideline update: plasmapheresis in neurologic disorders: report of the therapeutics and technology assessment subcommittee of the American academy of neurology, Neurology, 76, 294, 10.1212/WNL.0b013e318207b1f6

1997, Appropriate number of plasma exchanges in guillain-barré syndrome. The French cooperative group on plasma exchange in guillain-barré syndrome, Ann. Neurol., 41, 298, 10.1002/ana.410410304

1987, Efficiency of plasma exchange in Guillain-Barré syndrome: role of replacement fluids. French Cooperative Group on Plasma Exchange in Guillain-Barré syndrome, Ann. Neurol., 22, 753, 10.1002/ana.410220612

Kesici, 2019, A novel treatment strategy for severe guillain-barré syndrome: zipper method, J. Child Neurol., 34, 277, 10.1177/0883073819826225

Hughes, 2016, Corticosteroids for guillain-barre syndrome, Cochrane Database Syst. Rev., 10

Wakerley, 2015, Mimics and chameleons in guillain-barre and miller Fisher syndromes, Pract. Neurol., 15, 90, 10.1136/practneurol-2014-000937

Lin, 2011, Risk factors and outcomes of Guillain-Barré syndrome with acute myelitis, Pediatr. Neurol., 44, 110, 10.1016/j.pediatrneurol.2010.08.013

Fourrier, 2011, A simple functional marker to predict the need for prolonged mechanical ventilation in patients with Guillain-Barre syndrome, Crit. Care, 15, R65, 10.1186/cc10043

Kuitwaard, 2009, Pharmacokinetics of intravenous immunoglobulin and outcome in Guillain-Barre syndrome, Ann. Neurol., 66, 597, 10.1002/ana.21737

Walgaard, 2018, Second IVIg course in Guillain-Barré syndrome patients with poor prognosis (SID-GBS trial): protocol for a double-blind randomized, placebo-controlled clinical trial, J. Peripher. Nerv. Syst., 23, 210, 10.1111/jns.12286

Verboon, 2017, Treatment dilemmas in Guillain-Barre syndrome, J. Neurol. Neurosurg. Psychiatry, 88, 346, 10.1136/jnnp-2016-314862

Ruts, 2010, Distinguishing acute-onset CIDP from fluctuating Guillain-Barre syndrome: a prospective study, Neurology, 74, 1680, 10.1212/WNL.0b013e3181e07d14

Nevo, 2000, 88th ENMC international workshop: childhood chronic inflammatory demyelinating polyneuropathy (including revised diagnostic criteria), Naarden, The Netherlands, December 8-10, Neuromuscul. Disord., 12, 195, 10.1016/S0960-8966(01)00286-3

Hughes, 2008, Intravenous immune globulin (10% caprylate-chromatography purified) for the treatment of chronic inflammatory demyelinating polyradiculoneuropathy (ICE study): a randomised placebo-controlled trial, Lancet Neurol., 7, 136, 10.1016/S1474-4422(07)70329-0

Garssen, 2007, Treatment of Guillain-Barre syndrome with mycophenolate mofetil: a pilot study, J. Neurol. Neurosurg. Psychiatry, 78, 1012, 10.1136/jnnp.2006.102731

Davidson, 2017, Inhibition of complement in Guillain-Barre syndrome: the ICA-GBS study, J. Peripher. Nerv. Syst., 22, 4, 10.1111/jns.12194

Pritchard, 2016, Pharmacological treatment other than corticosteroids, intravenous immunoglobulin and plasma exchange for Guillain-Barre syndrome, Cochrane Database Syst. Rev., 11

Khan, 2011, Outcomes of high- and low-intensity rehabilitation programme for persons in chronic phase after Guillain-Barre syndrome: a randomized controlled trial, J. Rehabil. Med., 43, 638, 10.2340/16501977-0826

Fisher, 2009

Hessenauer, 2018, Warum Physio- und Ergotherapie in der Post-Akutphase?

Khan, 2010, Use of the International Classification of Functioning, Disability and Health to describe patient-reported disability: a comparison of Guillain Barre syndrome with multiple sclerosis in a community cohort, J. Rehabil. Med., 42, 708, 10.2340/16501977-0592

Steffens, 2018, Notwendigkeit der Integration der Kernkompetenzen von Rehabilitation und Behinderung in den Nationalen Kompetenzbasierten Lernzielkatalog Medizin (NKLM), Rehabilitation, 57, 226, 10.1055/a-0651-5991

Thông tin
Thông tin xuất bản

European Journal of Paediatric Neurology

Tập 25

5-16

Thông tin tác giả